Testicular Tumor Cells
Testicular cancers, primarily arising from germ cells, represent a distinct group of malignancies that are often highly treatable but can present complex biological and clinical challenges. Our Testicular Tumor Cells collection provides a specialized set of models to investigate the pathogenesis, stemness properties, and therapeutic response of embryonal carcinomas and other germ cell tumors.
This portfolio includes well-characterized lines like the pluripotent NT2-D1, patient-derived embryonal carcinoma models (NEC15, NEC14, 833KE), and the unique NCR-G series representing complex type germ cell tumors. These models are essential tools for studying developmental pathways, epigenetic regulation, and mechanisms of chemotherapy sensitivity and resistance.
Germ Cell Origin Embryonal Carcinoma Focus Pluripotent Models Validated
Key Features & Expertise
Our testicular tumor cell lines are characterized to support research in germ cell tumor biology
Focused on Germ Cell & Embryonal Carcinoma Models
- Core models of embryonal carcinoma, the stem cell component of mixed germ cell tumors
- Includes the pluripotent NT2-D1 line, capable of differentiation into multiple lineages
- Features patient-derived models (NEC series, 833KE) and complex type germ cell tumors (NCR-G series)
Characterized for Pluripotency & Developmental Pathways
- Profiled for expression of pluripotency markers (OCT4, NANOG, SOX2)
- Suitable for studying differentiation, epigenetic regulation, and developmental signaling
- Models with documented sensitivity to cisplatin, a cornerstone of testicular cancer therapy
Quality-Controlled for Reliable Research
- STR-authenticated to confirm genetic identity and germ cell origin
- Includes mycoplasma-eliminated derivatives (e.g., NEC8) for critical studies
- Supplied with detailed characterization data and culture protocols
FAQ
What is the difference between embryonal carcinoma cell lines (like NEC15, NT2-D1) and the NCR-G series?
Embryonal carcinoma (EC) lines like NEC15 and NT2-D1 represent a pure histology of the stem cell component found in many mixed germ cell tumors. They are pluripotent and used to study stemness and differentiation. The NCR-G series are described as "complex type germ cell tumors," which may better model the heterogeneity and mixed cellular composition seen in some patient tumors, potentially containing multiple lineages.
Why is NT2-D1 a particularly important model for testicular cancer research?
NT2-D1 is a pluripotent human embryonal carcinoma cell line. It is one of the most well-characterized models of its kind and is widely used not only in testicular cancer research but also as a model for studying human embryonic development, differentiation (notably into neurons), and epigenetic regulation, due to its robust expression of core pluripotency factors.
Can these cell lines be used to study cisplatin resistance, a major clinical challenge?
While testicular cancers are generally cisplatin-sensitive, studying de novo or acquired resistance is crucial. Many of these embryonal carcinoma models are intrinsically sensitive to cisplatin, making them excellent tools for establishing resistant sublines. Comparing sensitive parent lines (like 833KE) to derived resistant variants can reveal key resistance mechanisms.
Are these cell lines suitable for differentiation studies?
Yes, absolutely. Embryonal carcinoma lines, especially NT2-D1, are classic models for studying differentiation. They can be induced to differentiate into various cell types (e.g., neuronal lineage) using agents like retinoic acid. This makes them valuable for researching the developmental biology of germ cell tumors and the effects of differentiation therapy.
How are these germ cell tumor lines authenticated?
All cell lines are STR (Short Tandem Repeat) profiled to confirm their unique genetic identity. This is essential to verify they are indeed of human testicular/germ cell origin and not a misidentified cell line, ensuring the validity of research findings in this specialized field.
What are the typical culture conditions for embryonal carcinoma cell lines?
Most embryonal carcinoma lines, including NT2-D1 and the NEC series, are cultured in DMEM or RPMI-1640 supplemented with 10% FBS. They are adherent cells. It's important to maintain them in an undifferentiated state by passaging before confluence; using low passage numbers is often recommended for stemness studies.
Filters Clear all filters
Species
- Cat (1)
- Human (989)
- Mouse (5)
- Rat (1)
Source
- Abdomen Metastasis (2)
- Adrenal Gland (7)
- Adrenal Gland Metastasis (2)
- Ascites (23)
- Ascites Metastasis (32)
- Bile Duct (3)
- Bladder (12)
- Blood (120)
- Bone (21)
- Bone Marrow (43)
- Bone Marrow Metastasis (18)
- Bone Metastasis (6)
- Brain (31)
- Brain Metastasis (6)
- Breast (8)
- Bronchus (1)
- Cecum (3)
- Cerebrospinal Fluid (1)
- Cerebrospinal Fluid Metastasis (1)
- Cervix (32)
- Colon (83)
- Cornea (3)
- Cutaneous Metastasis (1)
- Dermis (1)
- Duodenum (1)
- Endometrium (17)
- Esophagus (44)
- Eye (12)
- Eye Socket (5)
- Fetus (1)
- Foreskin (4)
- Gallbladder (1)
- Gingiva (2)
- Globe (2)
- Groin (1)
- Hypodermis Metastasis (5)
- Intestine (84)
- kidney (1)
- Kidney (9)
- Liver (13)
- Liver Metastasis (17)
- Lung (42)
- Lung Metastasis (8)
- Lymph Node (5)
- Lymph Node Metastasis (56)
- Muscle (4)
- Muscle Metastasis (2)
- Nose (2)
- Omentum Metastasis (2)
- Oral Cavity (10)
- Ovary (13)
- Ovary Metastasis (2)
- Pancreas (10)
- Pelvic Wall Metastasis (1)
- Pelvis (1)
- Perianal Space Metastasis (1)
- Pericardial Effusion (1)
- Pericardial Effusion Metastasis (1)
- Perineus (1)
- Peripheral Blood (119)
- Peritoneal Effusion (2)
- Peritoneum (1)
- Peritoneum Metastasis (1)
- Pharynx (3)
- Pleural Effusion (54)
- Pleural Effusion Metastasis (44)
- Prostate (4)
- Rectum (13)
- Renal Pelvis (1)
- Retroperitoneal Space (2)
- Salivary Gland (2)
- Skeletal Muscle (1)
- Skin (22)
- Skin Metastasis (3)
- Small Intestine (1)
- Small Intestine Metastasis (1)
- Soft Tissue Metastasis (1)
- Stomach (4)
- Testis (9)
- Thoracic Cavity Metastasis (6)
- Thyroid Gland (15)
- Thyroid Gland Metastasis (1)
- Tongue (5)
- Umbilical Cord (1)
- Umbilical Cord Blood (1)
- Urachus (1)
- Ureter (1)
- Uterus (53)
- Uvea (2)
- Vagina (2)
- Vulva (1)
Disease
- Acute Biphenotypic Leukemia (1)
- Acute Erythroid Leukemia (4)
- Acute Megakaryoblastic Leukemia (4)
- Acute Monocytic Leukemia (9)
- Acute Myeloid Leukemia (25)
- Acute Promyelocytic Leukemia (2)
- Adrenal Gland Neuroblastoma (11)
- Adult B Acute Lymphoblastic leukemia (1)
- Adult B Acute Lymphoblastic Leukemia (6)
- Adult T Acute Lymphoblastic Leukemia (6)
- Adult T Lymphoblastic Lymphoma (2)
- Adult T-Cell Leukemia/Lymphoma (1)
- Alveolar Rhabdomyosarcoma (4)
- Alveolar Ridge Squamous Cell Carcinoma (1)
- Amelanotic Melanoma (3)
- Ampulla of Vater Adenocarcinoma (1)
- Ampulla of Vater Adenosquamous Carcinoma (3)
- Anaplastic Astrocytoma (3)
- Anaplastic Large Cell Lymphoma (7)
- Askin Tumor (1)
- Astrocytoma (5)
- B Acute Lymphoblastic Leukemia (2)
- B-Cell Non-Hodgkin Lymphoma (5)
- Bare Lymphocyte Syndrome Type 2 (1)
- Barrett Adenocarcinoma (2)
- Benign Prostatic Hyperplasia (1)
- Bladder Carcinoma (12)
- Bladder Squamous Cell Carcinoma (1)
- Breast Adenocarcinoma (1)
- Breast Carcinoma (9)
- Breast Ductal Carcinoma (2)
- Burkitt Lymphoma (17)
- Canavan Disease (1)
- Cecum Adenocarcinoma (3)
- Central Nervous System Lymphoma (2)
- Cervical Adenocarcinoma (2)
- Cervical Adenosquamous Carcinoma (2)
- Cervical Small Cell Carcinoma (1)
- Cervical Squamous Cell Carcinoma (2)
- Childhood B Acute Lymphoblastic Leukemia (13)
- Childhood T Acute Lymphoblastic Leukemia (16)
- Childhood T Lymphoblastic Lymphoma (1)
- Cholangiocarcinoma (2)
- Chronic Eosinophilic Leukemia (1)
- Chronic Lymphocytic Leukemia (2)
- Chronic Myeloid Leukemia (23)
- Clear Cell Renal Cell Carcinoma (2)
- Colon Adenocarcinoma (53)
- Colon Carcinoma (33)
- Colorectal Adenocarcinoma (1)
- Colorectal Carcinoma (1)
- Congenital Pure Red Cell Aplasia (1)
- Cutaneous Melanoma (10)
- Dedifferentiated Chondrosarcoma (1)
- Desmoplastic Melanoma (1)
- Diffuse Large B-Cell Lymphoma (28)
- Down Syndrome (2)
- EBV-Related Burkitt Lymphoma (12)
- Embryonal Carcinoma (3)
- Embryonal Rhabdomyosarcoma (3)
- Endometrial Adenocarcinoma (13)
- Endometrial Adenosquamous Carcinoma (2)
- Endometrial Carcinoma (2)
- Endometrioid Stromal Sarcoma (1)
- Epithelioid Hemangioendothelioma (1)
- Epithelioid Sarcoma (3)
- Esophageal Adenocarcinoma (6)
- Esophageal Squamous Cell Carcinoma (41)
- Essential Thrombocythemia (1)
- Ewing Sarcoma (2)
- Extraskeletal Myxoid Chondrosarcoma (1)
- Fanconi Anemia (1)
- Fibrosarcoma (1)
- Follicular Lymphoma (2)
- Gallbladder Carcinoma (2)
- Gallbladder Undifferentiated Carcinoma (2)
- Gastric Adenocarcinoma (6)
- Gastric Adenosquamous Carcinoma (1)
- Gastric Carcinoma (5)
- Gastric Choriocarcinoma (1)
- Gastric Fundus Carcinoma (1)
- Gastric Signet Ring Cell Adenocarcinoma (1)
- Gastric Small Cell Carcinoma (2)
- Gastric Tubular Adenocarcinoma (5)
- Gastroesophageal Junction Adenocarcinoma (1)
- Gestational Choriocarcinoma (1)
- Gingival Squamous Cell Carcinoma (2)
- Glioblastoma (18)
- Gliosarcoma (1)
- Hairy Cell Leukemia (1)
- Hepatoblastoma (2)
- Hepatocellular Carcinoma (6)
- Hepatosplenic T-Cell Lymphoma (2)
- Hereditary Thyroid Gland Medullary Carcinoma (1)
- High Grade B-Cell Lymphoma (1)
- High Grade Ovarian Serous Adenocarcinoma (8)
- Hodgkin Lymphoma (9)
- Hypopharyngeal Squamous Cell Carcinoma (2)
- Infectious Mononucleosis (1)
- Intrahepatic Cholangiocarcinoma (6)
- Invasive Breast Carcinoma of No Special Type (12)
- Kidney Neoplasm (1)
- Kidney Rhabdoid Tumor (1)
- Krukenberg Tumor (1)
- Liposarcoma (1)
- Lung Adenocarcinoma (17)
- Lung Giant Cell Carcinoma (8)
- Lung Large Cell Carcinoma (9)
- Lung Mucoepidermoid Carcinoma (1)
- Lung Non-Small Cell Carcinoma (2)
- Lung Small Cell Carcinoma (25)
- Lung Squamous Cell Carcinoma (9)
- Lymphoblastic Lymphoma (1)
- Malignant Peripheral Nerve Sheath Tumor (1)
- Mantle Cell Lymphoma (5)
- Mature Gastric Teratoma (1)
- Maxillary Sinus Squamous Cell Carcinoma (1)
- Medulloblastoma (3)
- Melanoma (24)
- Meningioma (2)
- Minimally Invasive Lung Adenocarcinoma (1)
- Monophasic Synovial Sarcoma (1)
- Mouse Intestinal Tract Neuroendocrine Adenoma (1)
- Mouse Mammary Gland Malignant Neoplasm (2)
- Mouse Plasmacytoma (1)
- Mycosis Fungoides (1)
- Myelodysplastic Syndrome (1)
- Myxofibrosarcoma (1)
- Natural Killer Cell Lymphoblastic Leukemia/Lymphoma (2)
- Neuroblastoma (26)
- Oral Cavity Squamous Cell Carcinoma (15)
- Osteoid Osteoma (1)
- Osteosarcoma (15)
- Ovarian Carcinoma (1)
- Ovarian Clear Cell Adenocarcinoma (1)
- Ovarian Endometrioid Adenocarcinoma (4)
- Ovarian Granulosa Cell Tumor (1)
- Ovarian Mucinous Adenocarcinoma (2)
- Ovarian Serous Adenocarcinoma (2)
- Ovarian Serous Cystadenocarcinoma (2)
- Ovarian Small Cell Carcinoma (1)
- Pancreatic Adenocarcinoma (13)
- Pancreatic Carcinoma (5)
- Pancreatic Ductal Adenocarcinoma (12)
- Papillomavirus-Independent Cervical Squamous Cell Carcinoma (1)
- Papillomavirus-Related Cervical Adenocarcinoma (7)
- Papillomavirus-Related Cervical Squamous Cell Carcinoma (4)
- Papillomavirus-Related Endocervical Adenocarcinoma (16)
- Paroxysmal Nocturnal Hemoglobinuria (3)
- Pharyngeal Squamous Cell Carcinoma (1)
- Plasma Cell Myeloma (15)
- Pleural Epithelioid Mesothelioma (5)
- Pleural Sarcomatoid Mesothelioma (2)
- Poorly Differentiated Thyroid Gland Carcinoma (1)
- Primary Cutaneous T-Cell Non-Hodgkin Lymphoma (1)
- Primary Effusion Lymphoma (7)
- Primitive Neuroectodermal Tumor (1)
- Prostate carcinoma (1)
- Prostate Carcinoma (9)
- Rectal Adenocarcinoma (13)
- Rectosigmoid Adenocarcinoma (1)
- Recurrent Bladder Carcinoma (1)
- Renal Cell Carcinoma (7)
- Renal Pelvis Urothelial Carcinoma (1)
- Retinoblastoma (11)
- Sacral Chordoma (1)
- Sacrococcygeal Teratoma (1)
- Salivary Gland Squamous Cell Carcinoma (1)
- Sezary Syndrome (1)
- Shwachman-Diamond Syndrome (1)
- Skin Squamous Cell Carcinoma (2)
- Splenic Marginal Zone Lymphoma (1)
- Testicular Embryonal Carcinoma (8)
- Testicular Teratoma (2)
- Testicular Yolk Sac Tumor (1)
- Thyroid Gland Anaplastic Carcinoma (10)
- Thyroid Gland Follicular Carcinoma (4)
- Thyroid Gland Papillary Carcinoma (3)
- Thyroid Gland Sarcoma (1)
- Thyroid Gland Squamous Cell Carcinoma (2)
- Tongue Adenosquamous Carcinoma (1)
- Tongue Squamous Cell Carcinoma (6)
- Type I Endometrial Adenocarcinoma (1)
- Ureter Urothelial Carcinoma (1)
- Uterine Carcinosarcoma (2)
- Uterine Corpus Leiomyosarcoma (1)
- Uterine Corpus Sarcoma (2)
- Uveal Melanoma (2)
- Vaginal Melanoma (2)
- Vulvar Melanoma (1)
- Vulvar Squamous Cell Carcinoma (1)
Description: Species: human, Caucasian male 22 years; Tissue: testis; Tumor: carcinoma, embryonal pluripotent; ...
Description: Complex type germ cell tumor of human embryonic testis origin.
Description: Complex type germ cell tumor of human embryonic testis origin.
Description: Complex type germ cell tumor of human embryonic testis origin.
Description: A human embryonal carcinoma cell line derived from a human testicular germ cell tumour.







